يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"NASH non-alcoholic steatohepatitis"', وقت الاستعلام: 1.30s تنقيح النتائج
  1. 1

    المصدر: JHEP Reports, Vol 3, Iss 4, Pp 100293-(2021)
    JHEP Reports

  2. 2

    المصدر: JHEP reports : innovation in hepatology, vol 3, iss 3
    JHEP Reports
    JHEP Reports, Vol 3, Iss 3, Pp 100281-(2021)

    مصطلحات موضوعية: phosphatidylinositol, Cirrhosis, Steatosis, ALT, hexosylceramide, Humanised mice, SREBP, sterol regulatory element-binding protein, PI, RC799-869, CMHs, chimeric mouse hepatocytes, 0302 clinical medicine, GGT, gamma-glutamyl transpeptidase, aspartate aminotransferase, HCC, gamma-glutamyl transpeptidase, chemistry.chemical_classification, 0303 health sciences, education.field_of_study, Western-type diet, Gastroenterology, NASH, CHHs, Diseases of the digestive system. Gastroenterology, 3. Good health, confidence transcript, HCT, cholesteryl ester, human albumin, DCER, dihydroceramide, 030211 gastroenterology & hepatology, PC, non-alcoholic steatohepatitis, PE, transgene-free Il2rg-/-/Rag2-/-/Fah, free fatty acid, LPE, lysophosphatidylethanolamine, DCER, NASH, non-alcoholic steatohepatitis, HCER, hexosylceramide, NC, normal chow, TIRF, PE, phosphatidylethanolamine, nitisinone, lysophosphatidylethanolamine, 03 medical and health sciences, dihydroceramide, Human disease modelling, NAFLD, FFA, free fatty acid, LCER, DEG, MUFA, education, phosphatidylcholine, chimeric mouse hepatocytes, FAH, SM, sphingomyelin, ALP, alkaline phosphatase, FA, fatty acid, NTBC, Fatty acid, medicine.disease, differentially expressed gene, lactosylceramide, PNPLA3, patatin-like-phospholipase domain-containing protein 3, Lipid metabolism, chemistry, fatty acid, PUFA, hALB, human albumin, TIRF, transgene-free Il2rg-/-/Rag2-/-/Fah, AST, aspartate aminotransferase, CT, confidence transcript, PC, phosphatidylcholine, monounsaturated fatty acid, DEG, differentially expressed gene, MUFA, monounsaturated fatty acid, Immunology and Allergy, MAG, monoacylglycerol, PUFA, polyunsaturated free FA, CE, cholesteryl ester, CER, diacylglycerol, FAH, fumarylacetoacetate hydrolase, Fatty liver, SM, chimeric human hepatocytes, hepatocellular carcinoma, CBPEGs, cholesterol biosynthesis pathway enzyme genes, CE, MAG, LPC, patatin-like-phospholipase domain-containing protein 3, triacylglycerol, LPE, alkaline phosphatase, sterol regulatory element-binding protein, Polyunsaturated fatty acid, Research Article, CT, NAFLD, non-alcoholic fatty liver disease, FA, HCER, TAG, triacylglycerol, fumarylacetoacetate hydrolase, monoacylglycerol, alanine aminotransferase, Population, cholesterol biosynthesis pathway enzyme genes, Biology, SREBP, PI, phosphatidylinositol, sphingomyelin, lysophosphatidylcholine, WD, ALT, alanine aminotransferase, high confidence transcriptional target, Internal Medicine, medicine, CBPEGs, ceramide, hALB, LCER, lactosylceramide, normal chow, AST, polyunsaturated free FA, WD, Western-type diet, PNPLA3, 030304 developmental biology, Hepatitis, LPC, lysophosphatidylcholine, Hepatology, DAG, non-alcoholic fatty liver disease, NTBC, nitisinone, CMHs, GGT, HCT, high confidence transcriptional target, phosphatidylethanolamine, TAG, Cancer research, CHHs, chimeric human hepatocytes, ALP, Liver function, NC, CER, ceramide, HCC, hepatocellular carcinoma, FFA, DAG, diacylglycerol, Non-alcoholic fatty liver disease

    وصف الملف: application/pdf

  3. 3

    المصدر: JHEP Reports
    JHEP Reports, Vol 3, Iss 3, Pp 100284-(2021)

    مصطلحات موضوعية: SREBP, sterol response element binding protein, Alcoholic liver disease, LDs, lipid droplets, MBOAT7, membrane bound O-acyltransferase domain-containing 7, AA, arachidonic acid, PPAR, peroxisome proliferator-activated receptor, RC799-869, Disease, Review, Bioinformatics, TNF-α, tumour necrosis factor-α, Liver disease, GPR55, G protein-coupled receptor 55, Immunology and Allergy, IL-, interleukin, HFE, homeostatic iron regulator, genetics, GCKR, glucokinase regulator, PNPLA3, patatin like phospholipase domain containing 3, Fatty liver, Gastroenterology, Diseases of the digestive system. Gastroenterology, FGF19, fibroblast growth factor 19, Lipotoxicity, ASH, alcoholic steatohepatitis, PRS, polygenic risk score, FFAs, free fatty acids, HSC, hepatic stellate cells, alcoholic liver disease, IL32, TAG, triacylglycerol, precision medicine, NASH, non-alcoholic steatohepatitis, interleukin-32, HSD17B13, hydroxysteroid 17-beta dehydrogenase 13, steatohepatitis, DNL, de novo lipogenesis, MBOAT7, ER, endoplasmic reticulum, FLD, fatty liver disease, FXR, farnesoid X receptor, Internal Medicine, medicine, Genetic predisposition, PNPLA3, therapy, LPI, lysophosphatidyl-inositol, Hepatology, business.industry, cirrhosis, PUFAs, polyunsaturated fatty acids, non-alcoholic fatty liver disease, medicine.disease, Mitochondrial amidoxime reducing component 1, MARC1, mitochondrial amidoxime reducing component 1, fatty liver disease, Steatohepatitis, business, HCC, hepatocellular carcinoma, DAG, diacylglycerol